Archive for July, 2020

A Henrico County-based laboratory company said Tuesday that it is planning to hire about 400 employees as it ramps up its testing capability for the virus that causes COVID-19.

Genetworx, a molecular diagnostic testing lab, said it has immediate hiring needs for jobs such as data entry, lab technicians, tech assistants, project managers, business managers, hiring managers and other work at its facility in the Innsbrook Corporate Center in western Henrico.

We are working 24 hours a day, said Brian ONeill, the companys founder. We have all the equipment to do 100,000 tests a day, and we have the customers. The United States is experiencing a massive demand for COVID-19 testing. We are running three shifts, flat out, and we need to hire at least another 400 people in the next several weeks.

Genetworx now employs about 350 people in the Richmond area, ONeill said. The company also has a laboratory near Philadelphia that is hiring.

It opened its Henrico laboratory in 2013 to do molecular testing for cancer, respiratory illness, genetic testing and other lab work.

With the coronavirus pandemic, the company started offering COVID-19 tests.

We were very busy before this, but we are extremely busy now, he said.

ONeill said jobs would pay between $40,000 and $100,000 a year.

We are willing to train smart people that want to come work for us, he said. We have a program called Re-employing America, and we are targeting people whose jobs were affected by the pandemic, and others. We are also hiring people from the laboratory industry and the health care industry as other labs have seen their work decrease because of less visits to health care.

Genetworx initially leased space in the former Innsbrook Library branch in 2013. Last month, the company leased 19,335 square feet of office space at the Park III building at 4144 Innslake Drive.

ONeill said it now has about 80,000 square feet of space in the two buildings.

See the original post here:
Henrico laboratory hiring 400 as it ramps up COVID-19 testing - Richmond.com

BANGALORE, July 8, 2020 /PRNewswire/ -- Eurofins Clinical Genetics is accredited by NABL & approved by ICMR to perform COVID-19 RT-PCR based testing (ViroSure-19). Eurofins new facility in Peenya, Bangalore is dedicated to Virology testing. Eurofins India has taken steps to support community by starting COVID-19 testing.

The ViroSure-19 test helps clinicians to detect the presence of COVID-19 in human respiratory samples. This diagnostic test offers fast detection of infection and facilitates emergency medical aid to patients before it is too late. Coming from a multinational brand, known for its accuracy and reliability in clinical diagnostics, ViroSure-19 is a sure bet in COVID-19 diagnosis. Today, COVID-19 test is ray of hope to millions of people across the globe and an effective solution like ViroSure-19 becomes a powerful armor to defeat the virus spread.

According to the Eurofins Clinical Genetics BU Head, Mr. Sudhanshu Srivastava,"Eurofins laboratories are fully operational to support patients & families through COVID testing & counseling".The ViroSure-19 is real-time multiplex PCR to detect SARS-CoV-2 in the most efficient way possible. Within a quarter, the team worked rigorously with specialists across organizations team of scientists on building the right test and contributing scientific excellence in infectious disease testing.

Eurofins, has been a very established company with regard to testing services for over 35 years. Eurofins India is now well-prepared to deliver COVID-19 testing across the country. Always recognized for the reliability and accuracy indexes of their products, ViroSure-19has been thoroughly examined by the Eurofins R&D team. As accredited by NABL and approved by ICMR, the ViroSure-19 provided precise results throughout the final testing period. Dr. Sam Balu, Asst. Lab Director, Eurofins Clinical Genetics, said, "I amexpecting a break in the cloud amidst this pandemic situation and hoping for ViroSure-19 diagnosis to help save lives." It will hence help reduce the risk of community spread of the virus amongst Indian metropolitan cities, detect COVID-19 positive cases precisely, and contribute to the fight, the world is pursuing against the global pandemic. Eurofins Clinical Genetics services based on NGS including Exome testing & prenatal testing remain functional throughout lockdown period to serve patients. Eurofins Clinical Genetics has also developed SARS-CoV-2 genome sequencing studies supporting various research organizations to develop preventive strategies against novel corona virus.

About Eurofins

Pioneering in food, environment, pharmaceutical, clinical diagnostics, cosmetic products testing solutions and genetic testing Eurofins remains the global leader with its superior industry standards in quality, accuracy, affordability, and global presence. The number of testing facilities has reached as large as 800 in 50 countries and fast expanding to many more locations. Started as Eurofins Scientific in 1987, the company started to grow with a mission of contributing to a safer and healthier world and never looked back after 2002. Due to unprecedented times, the company's objectives have been directed towards drawing scientific experience to develop a range of SARS-CoV-2 tests in response to the Coronavirus pandemic. To know more about COVID-19 testing at Eurofins India, please connect via mail at salesecgi@eurofins.com or give them a callat +91-95135-20807/ +91-806722-3200.

For details, please visit: https://www.eurofinsclinicalgenetics.co.in/

Media Contact:Eurofins Indiasalesecgi@eurofins.com+91-95135-20807Eurofins Clinical Genetics India Pvt. Ltd.

More here:
Eurofins, the World Leader in Bio-analytical Testing, Launches ViroSure-19, One of the Most Accurat - PharmiWeb.com

Orphan Drug Designation granted to Neurogenes adeno-associated virus vector with engineered transgene encoding the human CLN5 gene

Neurogene Inc., a company founded with a mission to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation to adeno-associated virus vector with engineered transgene encoding the human CLN5 gene for patients with CLN5, a form of Batten disease. Batten disease, a common name for a rare class of diseases called neuronal ceroid lipofuscinoses (NCL), affects an estimated 2-4 out of every 100,000 children in the United States.

"CLN5 is a devastating neurodegenerative disease with no FDA approved treatment options," said Rachel McMinn, Ph.D., Neurogenes Founder and Chief Executive Officer. "Receiving Orphan Drug Designation from the FDA is an important regulatory milestone, and we look forward to advancing our gene therapy program into the clinic."

The FDA grants Orphan Drug Designation to drugs and biologics intended for the safe and effective treatment, diagnosis or prevention of rare diseases or conditions affecting fewer than 200,000 people in the United States. Orphan Drug Designation provides benefits to drug developers designed to support the development of drugs and biologics for small patient populations with unmet medical needs. These benefits include assistance in the drug development process, tax credits for clinical costs, exemptions from certain FDA fees and seven years of marketing exclusivity.

About CLN5Batten disease, also called neuronal ceroid lipofuscinoses (NCLs), is a family of rare and fatal neurodegenerative diseases caused by pathogenic changes in one of a series of genes that result in the accumulation of abnormal storage material across multiple organ systems, including the brain, eye, skin and other tissues. The most prominent effects occur in the brain, where the progressive and inevitable loss of neurons lead to devastating declines in cognitive and motor function in those with Batten disease. The subtype CLN5 is a rare, pediatric-onset and rapidly progressive disease caused by defects in the CLN5 gene. CLN5 disease is characterized by progressive deterioration in intellectual and motor capabilities and vision loss, as well as seizures and death in childhood or adolescence. Diagnosis of the disease is confirmed through genetic testing. Currently, there are no approved disease-modifying therapies available.

About Genetic TestingNeurogene is committed to lowering the barriers of obtaining a genetic diagnosis for patients and has partnered with Invitae to co-sponsor two genetic testing programs. Healthcare providers can order, at no charge, an Invitae Epilepsy panel for any child under the age of eight who has had an unprovoked seizure, or the Detect Lysosomal Storage Diseases panel for patients suspected of having a lysosomal storage disease. Visit https://www.invitae.com/en/sponsored-testing/ for more details.

About Neurogene Inc.Neurogene Inc. is focused on developing life-changing genetic medicines for patients and their families affected by rare, devastating neurological diseases. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring therapies to patients that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs are designed to use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy. For more information, visit http://www.neurogene.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200707005106/en/

Contacts

Nikki Kiddnikki.kidd@rturnmktg.com 773-257-7523

Originally posted here:
FDA Grants Orphan Drug Designation to Neurogenes Gene Therapy for the Treatment of CLN5 Batten Disease - Yahoo Finance

Global Point-Of-Care Genetic Testing market study presents an in-depth scenario which is segmented according to manufacturers, product type, applications, and regions. This segmentation will provide deep-dive analysis of the Point-Of-Care Genetic Testing industry for identifying the growth opportunities, development trends and factors limiting the growth of the market. This report offers forecast market information based on past and present Point-Of-Care Genetic Testing industry situations and growth aspects. All the key regions covered in Point-Of-Care Genetic Testing report are North America, Europe, Asia-Pacific, South America, Middle East and Africa. The Point-Of-Care Genetic Testing market share and market outlook of each region from 2020-2027 are presented in this report. A deep study of Point-Of-Care Genetic Testing market dynamics will help the market aspirants in identifying the business opportunities which will lead to accumulation of revenue. This segment can effectively determine the Point-Of-Care Genetic Testing risk and key market driving forces.

Request Sample Report @ https://www.futuremarketinsights.co/reports/sample/REP-GB-3138

Initially, the report presents the Point-Of-Care Genetic Testing market overview covering product description, market analysis, market dynamics, opportunities and market share. Secondly, global report conducts a qualitative analysis to present the key manufacturers profile, Point-Of-Care Genetic Testing market share, market size, sales volume, gross margin analysis.

The Point-Of-Care Genetic Testing report is segmented to provide a clear and precise view of the global Point-Of-Care Genetic Testing market statistics and market estimates. Point-Of-Care Genetic Testing report Data represented in the form of graphs, charts, and figures will show the Point-Of-Care Genetic Testing growth rate, volume, target consumer analysis. This report presents the crucial data to all Point-Of-Care Genetic Testing industry aspirants which will facilitate useful business decisions.

Key Players

Cepheid, IQuum, Biocartis, Abbott, Idaho Technologies, ThermoFisher, Roche, Optigene, Lumora are some of the global key players in point-of-care genetic testing. In 2016, Biocartis Idyllas distribution rights were also granted to Thermofisher in the US. The Idylla platform is a fully integrated system enabling laboratories to perform a broad range of applications in oncology and beyond. But in 2014, Iquums Liat Analyzers rights were acquired by Roche Molecular Diagnostics.

The report covers exhaustive analysis on:

The regionalanalysis includes:

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Report Highlights:

Detailed overview of parent market

Changing market dynamics in the industry

In-depth market segmentation

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape

Strategies of key players and products offered

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on market performance

Must-have information for market players to sustain and enhance their market footprint

NOTE All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Future Market Insights.

Request Methodology On This Report @ https://www.futuremarketinsights.co/askus/REP-GB-3138

The Point-Of-Care Genetic Testing report cover following data points:

Part 1: This part enlists the global Point-Of-Care Genetic Testing market overview, covering the basic market introduction, market analysis by type, applications, and regions. The major Point-Of-Care Genetic Testing producing regions include North America, Europe, Asia-Pacific, Middle-East, and Africa. Point-Of-Care Genetic Testing industry states and outlook (2020-2027) is presented in this part. In addition, Point-Of-Care Genetic Testing market dynamics stating the opportunities, market risk, and key driving forces are studied.

Part 2: This part covers Point-Of-Care Genetic Testing manufacturers profile based on their business overview, product type, and application. Also, the sales volume, Point-Of-Care Genetic Testing product price, gross margin analysis, and Point-Of-Care Genetic Testing market share of each player is profiled in this report.

Part 3 and Part 4: This part presents the Point-Of-Care Genetic Testing competition based on sales, revenue, and market share of each manufacturer. Part 4 covers the Point-Of-Care Genetic Testing market scenario based on regions. Region-wise Point-Of-Care Genetic Testing sales and growth (2015-2019) is studied in this report.

Part 5 and Part 6: These two sections cover the North America and Europes Point-Of-Care Genetic Testing industry by countries. Under this the Point-Of-Care Genetic Testing revenue, market share of the countries like USA, Canada, and Mexico is provided. Under Europe Point-Of-Care Genetic Testing report includes, the countries like Germany, UK, France, Russia, Italy, Russia and their sales and growth is covered.

Part 7, Part 8 and Part 9: These 3 sections covers Point-Of-Care Genetic Testing sales revenue and growth for the regions like Asia-Pacific, South America, Middle East & Africa. Under these regions Point-Of-Care Genetic Testing report covered, the countries like China, Japan, Korea, India, Brazil, Columbia, Argentina, Egypt, Saudi Arabia, Nigeria and South Africa. The sales and growth in these regions are presented in this Point-Of-Care Genetic Testing industry report.

We offer tailor-made solutions to fit your requirements, request[emailprotected] https://www.futuremarketinsights.co/customization-available/REP-GB-3138

Part 10 and Part 11: This part depicts the Point-Of-Care Genetic Testing market share, revenue, sales by product type and application. The Point-Of-Care Genetic Testing sales growth seen during 2012-2020 is covered in this report.

Part 12 and Part 13: This part provides forecast information related to Point-Of-Care Genetic Testing market (2020-2027) for each region. The sales channels including direct and indirect Point-Of-Care Genetic Testing marketing, traders, distributors, and future trends are presented in this report.

Part 14 and Part 15: These parts present Point-Of-Care Genetic Testing market key research findings and conclusion, research methodology, and data sources are covered.

Thus, Global Point-Of-Care Genetic Testing report is a complete blend covering all the vital market aspects.

More:
Soaring Demand for Clean-label Food Products to Trigger the Growth of the Point-Of-Care Genetic Testing Market 2017-2027 - Cole of Duty

LOS ANGELES, July 7, 2020 /PRNewswire/ -- The Prostate Cancer Foundation (PCF) has collaborated with a consortium of 41 leading patient advocacy organizations, professional societies and industry partners to publish a white paper detailing recommendations for the use of testing terminology in precision medicine for patient education throughout the cancer community. Use of consistent language will significantly improve patient awareness and understanding of potentially life-saving testing options available for both new cancer diagnoses and progression or recurrence of disease. In prostate cancer, testing is a crucial tool that may reveal additional treatment options and/or information for a man's family about their own cancer risk.

Research shows that despite widespread acceptance of the importance of testing, actual testing rates lag far behind best-practice recommendations for both biomarker testing for somatic (acquired) mutations and other biomarkers, and for germline genetic testing for identifying germline (inherited) mutations (also known as variants). Analysis by The Consistent Testing Terminology Working Group (Working Group) indicates that language disparity is a primary obstacle to patient communication with providers about testing for their specific cancer type. Further, development of consistent language can increase patient understanding and communication, facilitate shared decision making, support value-based care and assure concordance in policy development.

"Both types of testing biomarker testing and genetic testing for inherited cancer risk are important in the care of prostate cancer patients," said Dr. Andrea Miyahira, Director of Global Research and Scientific Communications at PCF. "One example is the very recent approval of medications for men with advanced prostate cancer and certain mutations in their tumor or inherited mutations that would be revealed through testing. Therefore, clear terminology and understanding between patients and providers is all the more vital. PCF supports this valuable collaboration across cancer types."

The Working Group is a consortium of 20 cancer patient advocacy groups representing solid tumor and hematologic malignancies, three professional societies, and 18 pharmaceutical and diagnostic companies and testing laboratories. Over the course of many years, multiple activities, led by numerous individual patient advocacy organizations and professional societies have developed the groundwork for this effort. The Working Group has launched a multi-faceted dissemination and communications effort to ensure that its recommendations and supporting materials are widely available among all key stakeholders within the cancer ecosystem, including providers, patient advocacy organizations, guidelines agencies, payers, and policymakers.

In developing its recommendations, the Working Group, first convened in 2019 by LUNGevity Foundation, identified 33 terms related to biomarker, genetic and genomic testing that were being used in patient education and clinical care within the different cancer communities. In many cases, multiple terms were used to describe the same test. Various testing modalities, the source of testing samples, and the multiplicity of gene mutations currently identifiable by testing, were contributing factors in this often-confusing overlap.

In the final analysis, three umbrella descriptor terms emerged as recommendations from the Working Group's milestone exploration: "Biomarker testing" was selected as the preferred term for tests that identify characteristics, targetable findings or other test results originating from malignant tissue and blood; "genetic testing for an inherited mutation" and "genetic testing for inherited cancer risk" were selected as consensus terms for tests used to identify germline (inherited) mutations.

"Far too many patients across all cancer types are still missing out on essential tests for biomarkers and inherited mutations indicating cancer risk," said Michelle Shiller, DO, AP/CP, MGP, Co-Medical Director of Genetics at Baylor Sammons Cancer Center and Staff Pathologist at Baylor University Medical Center. "With rates of biomarker testing and genetic testing for an inherited mutation at sub-optimal levels for numerous patient populations, patients are not benefiting from biomarker-directed care or not learning about their inherited cancer risk. Confusion around testing terms is a driving factor in this undertesting and ultimately has a detrimental impact on patient care."

"When someone is diagnosed with cancer, they're swept into a whirlwind of bewildering words and complex, pressing decisions. Our Working Group's goal is to help calm that storm of confusion with clear and consistent language that facilitates communication and medical decision-making. A unified voice and message from providers, industry and the patient advocacy community about testing is absolutely vital to optimal cancer care," said Nikki Martin, Director of Precision Medicine Initiatives at LUNGevity Foundation.

An abstract on the Working Group's recommendations was published in May 2020 as part of the American Society of Clinical Oncology (ASCO) Annual Meeting Virtual Library. The White Paper can be viewed in its entirety athttp://www.commoncancertestingterms.org/.

About LUNGevity Foundation LUNGevity Foundation is the nation's leading lung cancer organization focused on improving outcomes for people with lung cancer through research, education, policy initiatives, and support and engagement for patients, survivors, and caregivers. LUNGevity seeks to make an immediate impact on quality of life and survivorship for everyone touched by the diseasewhile promoting health equity by addressing disparities throughout the care continuum. LUNGevity works tirelessly to advance research into early detection and more effective treatments, provide information and educational tools to empower patients and their caregivers, promote impactful public policy initiatives, and amplify the patient voice through research and engagement. The organization provides an active community for patients and survivorsand those who help them live better and longer lives.

Comprehensive resources include a medically vetted and patient-centric website, a toll-free HELPLine for support, the International Lung Cancer Survivorship Conference, and an easy-to-use Clinical Trial Finder, among other tools. All of these programs are to achieve our visiona world where no one dies of lung cancer. LUNGevity Foundation is proud to be a four-star Charity Navigator organization. Please visit http://www.LUNGevity.org to learn more.

About the Prostate Cancer Foundation The Prostate Cancer Foundation (PCF) is the world's leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has raised more than $830 million in support of cutting-edge research by more than 2,200 research projects at 220 leading cancer centers in 22 countries around the world. Thanks in part to PCF's commitment to ending death and suffering from prostate cancer, the death rate is down more than 50% and countless more men are alive today as a result. PCF research now impacts more than 73 forms of human cancer by focusing on immunotherapy, the microbiome, and food as medicine. For more information, visit PCF.org.

Media Contact: Donald Wilson Prostate Cancer Foundation (310) 428-4730 press@pcf.org

View original content to download multimedia:http://www.prnewswire.com/news-releases/the-prostate-cancer-foundation-collaboration-with-pan-cancer-consortium-clarifies-and-promotes-consistent-use-of-common-terms-for-biomarker-and-germline-genetic-testing-301088974.html

SOURCE Prostate Cancer Foundation

Read the original post:
The Prostate Cancer Foundation Collaboration With Pan-Cancer Consortium Clarifies And Promotes Consistent Use Of Common Terms For Biomarker And...

SALT LAKE CITY, July 06, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics and precision medicine, today announced a new collaboration with OptraHEALTH® to implement a cognitive ChatBOT named Gene to provide genetic and financial assistance information to prospective patients. Gene is an AI-powered, HIPAA-compliant knowledge platform for genetic health with BOT interfaces and can answer over 500,000 health related questions pertaining to hereditary cancer. Gene interfaces with Myriad’s market leading online hereditary cancer quiz, which is now taken by approximately one million people per year.

We are excited to offer this innovative new tool for physicians and patients to provide best-in-class pre-test education solutions that we can supplement with live sessions when necessary,” said Nicole Lambert, president of Myriad International, Oncology and Women’s Health. Myriad is highly focused on making the screening and testing process as streamlined as possible for healthcare providers and the implementation of this new technology will give their patients access to unparalleled online genetic education and support tools. This is especially important in the current environment with COVID-19 where patients may not be returning to the clinic setting and pre-test education can be particularly helpful as they work remotely with the healthcare provider to determine if testing is right for them.”

Gene will interactively engage individuals online, providing them with education about hereditary cancer prior to taking an online assessment to determine if they may be a candidate for genetic testing. For those who complete the preliminary assessment and meet criteria for further evaluation, Gene will automate a pre-test process that sends an educational link that displays interactive multimedia content and gives the option to start a live conversation with a patient educator, who is a certified genetic counselor. Gene can also assist in finding a healthcare provider who can help a patient make an informed, definitive decision whether testing is appropriate and then order testing if so. Myriad plans on launching the Gene chatbot for its Foresight® and Prequel prenatal tests and for companion diagnostic testing in oncology later this calendar year.

About OptraHEALTH: OptraHEALTH is focused on improving outcomes for consumers and leading Life Sciences and Healthcare organizations by utilizing a next-generation Artificial Intelligence Platform. OptraHEALTH’s flagship product GeneFAX is an AI-powered knowledge platform for genetic health and is available as a web plugin or mobile application.

About Myriad Genetics Myriad Genetics Inc., is a leading personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: transitioning and expanding its hereditary cancer testing markets, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets. For more information on how Myriad is making a difference, please visit the Company's website: http://www.myriad.com.

Myriad, the Myriad logo, BART, BRACAnalysis, Colaris, Colaris AP, myPath, myRisk, Myriad myRisk, myRisk Hereditary Cancer, myChoice, myPlan, BRACAnalysis CDx, Tumor BRACAnalysis CDx, myChoice CDx, Vectra, Prequel, Foresight, GeneSight, Prolaris and riskScore are trademarks or registered trademarks of Myriad Genetics, Inc. or its wholly owned subsidiaries in the United States and foreign countries. MYGN-F, MYGN-G.

Safe Harbor Statement This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to implementation of this new technology giving patients access to unparalleled online genetic education and support tools; plans to launch the Gene chatbot for its ForeSight® and Prequel prenatal tests and for hereditary cancer testing in oncology later this calendar year; details of the functionality of the Gene chatbot; and the Company's strategic directives under the caption "About Myriad Genetics." These "forward-looking statements" are based on management's current expectations of future events and are subject to a number of risks and uncertainties that could cause actual results to differ materially and adversely from those set forth in or implied by forward-looking statements. These risks and uncertainties include, but are not limited to: uncertainties associated with COVID-19, including its possible effects on our operations and the demand for our products and services; our ability to efficiently and flexibly manage our business amid uncertainties related to COVID-19; the risk that sales and profit margins of our molecular diagnostic tests and pharmaceutical and clinical services may decline; risks related to our ability to transition from our existing product portfolio to our new tests, including unexpected costs and delays; risks related to decisions or changes in governmental or private insurers’ reimbursement levels for our tests or our ability to obtain reimbursement for our new tests at comparable levels to our existing tests; risks related to increased competition and the development of new competing tests and services; the risk that we may be unable to develop or achieve commercial success for additional molecular diagnostic tests and pharmaceutical and clinical services in a timely manner, or at all; the risk that we may not successfully develop new markets for our molecular diagnostic tests and pharmaceutical and clinical services, including our ability to successfully generate revenue outside the United States; the risk that licenses to the technology underlying our molecular diagnostic tests and pharmaceutical and clinical services and any future tests and services are terminated or cannot be maintained on satisfactory terms; risks related to delays or other problems with operating our laboratory testing facilities and our healthcare clinic; risks related to public concern over genetic testing in general or our tests in particular; risks related to regulatory requirements or enforcement in the United States and foreign countries and changes in the structure of the healthcare system or healthcare payment systems; risks related to our ability to obtain new corporate collaborations or licenses and acquire new technologies or businesses on satisfactory terms, if at all; risks related to our ability to successfully integrate and derive benefits from any technologies or businesses that we license or acquire; risks related to our projections about our business, results of operations and financial condition; risks related to the potential market opportunity for our products and services; the risk that we or our licensors may be unable to protect or that third parties will infringe the proprietary technologies underlying our tests; the risk of patent-infringement claims or challenges to the validity of our patents or other intellectual property; risks related to changes in intellectual property laws covering our molecular diagnostic tests and pharmaceutical and clinical services and patents or enforcement in the United States and foreign countries, such as the Supreme Court decisions in Mayo Collab. Servs. v. Prometheus Labs., Inc., 566 U.S. 66 (2012), Ass’n for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), and Alice Corp. v. CLS Bank Int’l, 573 U.S. 208 (2014); risks of new, changing and competitive technologies and regulations in the United States and internationally; the risk that we may be unable to comply with financial operating covenants under our credit or lending agreements; the risk that we will be unable to pay, when due, amounts due under our credit or lending agreements; and other factors discussed under the heading "Risk Factors" contained in Item 1A of our most recent Annual Report on Form 10-K for the fiscal year ended June 30, 2019, which has been filed with the Securities and Exchange Commission, as well as any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on Form 8-K. All information in this press release is as of the date of the release, and Myriad undertakes no duty to update this information unless required by law.

Excerpt from:
Myriad Announces Partnership with OptraHEALTH to Deliver "Gene(TM)" a New AI Based Information Tool for Hereditary Cancer Patients |...

As reported in an eye-opening new research paper, scientists have created tiny human livers out of human skin cells before successfully transplanting them into rats.

What we are planning to do is to start making mini human organs that are universal, explained the papers co-author, Alejandro Soto-Gutirrez, from the University of Pittsburgh.That would change the paradigm of transplants.

The science-fiction-like procedure was done by taking adult skin cells and genetically altering certain genes and transcription factors to create what are known as pluripotent stem cells.

It starts with human skin cells called fibroblasts, in 2006 the pioneering field of genetic-editing led scientists to discover that they can simply take any cell from a living adult and turn it into a pluripotent stem cell.

Pluri, meaning plurality, indicates its ability to carry the genetic code of all organ types, which is how they can become liver cells.

RELATED: For the First Time in the US, Surgeons Pump New Life into Dead Donor Heart for Life-Saving Transplant

According to the Mayo Clinic, the number of people on current waiting lists for liver transplants far exceeds the number of available liver donors. The cost is just as high: the medical journal Inverse reports the average cost of a transplant, accounting for the entire procedure, is about $812,000.

New technologies always reduce the cost of existing products (remember how expensive flat screen televisions were?) and a new paradigm of made-to-order fabrication of organs would likely fulfill all the demand for transplants while lowering the cost at the same time.

As fascinating as it is a little unsettling, the science took a decade to perfect, but is far still from human trials. The tiny organs from human cells continued working normally after they were transplanted into rats bred to have suppressed immune systems otherwise the body would reject the foreign organ.

RELATED: Game-Changing Approval of Liver Transplant Procedure Expected to Halve the Waiting List

The method and associated technology could produce part-time liver grafts, that could prolong the lives of people waiting on the transplant list.

The long-term goal is to create organs that can replace organ donation, but in the near future, I see this as a bridge to transplant, Soto-Gutirrez told Inverse. For instance, in acute liver failure, you might just need a hepatic boost for a while, instead of a whole new liver.

(File photo by OPCW Laboratory in Rijswijk, CC license)

YOUR Friends May Be On The Waiting List For Good NewsShare on Social Media

Read this article:
Dream of Plentiful Organ Transplants Moves Closer to Reality as Scientists Grow Tiny Working Livers from Skin Cells - Good News Network

Global Stem Cell Therapy Market: Overview

Also called regenerative medicine, stem cell therapy encourages the reparative response of damaged, diseased, or dysfunctional tissue via the use of stem cells and their derivatives. Replacing the practice of organ transplantations, stem cell therapies have eliminated the dependence on availability of donors. Bone marrow transplant is perhaps the most commonly employed stem cell therapy.

Osteoarthritis, cerebral palsy, heart failure, multiple sclerosis and even hearing loss could be treated using stem cell therapies. Doctors have successfully performed stem cell transplants that significantly aid patients fight cancers such as leukemia and other blood-related diseases.

Know the Growth Opportunities in Emerging Markets

Global Stem Cell Therapy Market: Key Trends

The key factors influencing the growth of the global stem cell therapy market are increasing funds in the development of new stem lines, the advent of advanced genomic procedures used in stem cell analysis, and greater emphasis on human embryonic stem cells. As the traditional organ transplantations are associated with limitations such as infection, rejection, and immunosuppression along with high reliance on organ donors, the demand for stem cell therapy is likely to soar. The growing deployment of stem cells in the treatment of wounds and damaged skin, scarring, and grafts is another prominent catalyst of the market.

On the contrary, inadequate infrastructural facilities coupled with ethical issues related to embryonic stem cells might impede the growth of the market. However, the ongoing research for the manipulation of stem cells from cord blood cells, bone marrow, and skin for the treatment of ailments including cardiovascular and diabetes will open up new doors for the advancement of the market.

Global Stem Cell Therapy Market: Market Potential

A number of new studies, research projects, and development of novel therapies have come forth in the global market for stem cell therapy. Several of these treatments are in the pipeline, while many others have received approvals by regulatory bodies.

In March 2017, Belgian biotech company TiGenix announced that its cardiac stem cell therapy, AlloCSC-01 has successfully reached its phase I/II with positive results. Subsequently, it has been approved by the U.S. FDA. If this therapy is well- received by the market, nearly 1.9 million AMI patients could be treated through this stem cell therapy.

Another significant development is the granting of a patent to Israel-based Kadimastem Ltd. for its novel stem-cell based technology to be used in the treatment of multiple sclerosis (MS) and other similar conditions of the nervous system. The companys technology used for producing supporting cells in the central nervous system, taken from human stem cells such as myelin-producing cells is also covered in the patent.

The regional analysis covers:

Order this Report TOC for Detailed Statistics

Global Stem Cell Therapy Market: Regional Outlook

The global market for stem cell therapy can be segmented into Asia Pacific, North America, Latin America, Europe, and the Middle East and Africa. North America emerged as the leading regional market, triggered by the rising incidence of chronic health conditions and government support. Europe also displays significant growth potential, as the benefits of this therapy are increasingly acknowledged.

Asia Pacific is slated for maximum growth, thanks to the massive patient pool, bulk of investments in stem cell therapy projects, and the increasing recognition of growth opportunities in countries such as China, Japan, and India by the leading market players.

Global Stem Cell Therapy Market: Competitive Analysis

Several firms are adopting strategies such as mergers and acquisitions, collaborations, and partnerships, apart from product development with a view to attain a strong foothold in the global market for stem cell therapy.

Some of the major companies operating in the global market for stem cell therapy are RTI Surgical, Inc., MEDIPOST Co., Ltd., Osiris Therapeutics, Inc., NuVasive, Inc., Pharmicell Co., Ltd., Anterogen Co., Ltd., JCR Pharmaceuticals Co., Ltd., and Holostem Terapie Avanzate S.r.l.

About TMR Research:

TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in todays supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends.

Contact:

TMR Research,3739 Balboa St # 1097,San Francisco, CA 94121United StatesTel: +1-415-520-1050

See the original post:
Stem Cell Therapy Market Segmentation Detailed Study with Forecast to 2025 - Owned

The Skin Care Cosmetic market revenue was xx.xx Million USD in 2014, grew to xx.xx Million USD in 2018, and will reach xx.xx Million USD in 2024, with a CAGR of x.x% during 2019-2024. Based on the Skin Care Cosmetic industrial chain, this report mainly elaborates the definition, types, applications and major players of Skin Care Cosmetic market in details. Deep analysis about market status (2014-2019), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2019-2024), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Skin Care Cosmetic market., The Skin Care Cosmetic market can be split based on product types, major applications, and important regions.

Download PDF Sample of Skin Care Cosmetic Market report @ https://www.arcognizance.com/enquiry-sample/740561

Major Players in Skin Care Cosmetic market are:, Avon Products Inc, Kao Corporation, Procter & Gamble, The Estee Lauder Companies Inc, Beiersdorf AG, Unilever PLC, The Body Shop International PLC, Johnson & Johnson, LOreal S.A.

Major Regions that plays a vital role in Skin Care Cosmetic market are:, North America, Europe, China, Japan, Middle East & Africa, India, South America, Others

Brief about Skin Care Cosmetic Market Report with [emailprotected] https://arcognizance.com/report/global-skin-care-cosmetic-industry-market-research-report

Most important types of Skin Care Cosmetic products covered in this report are:, Sensitive Skin Care, Dry Skin Care, Infants Skin Care, Others

Most widely used downstream fields of Skin Care Cosmetic market covered in this report are:, Stem Cells Protection Against UV, Flakiness Reduction, Rehydrate the Skin Surface, Minimize wrinkles, Increase the viscosity of Aqueous

There are 13 Chapters to thoroughly display the Skin Care Cosmetic market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications and regions.

Chapter 1: Skin Care Cosmetic Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.

Chapter 2: Skin Care Cosmetic Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels and Major Downstream Buyers.

Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Skin Care Cosmetic.

Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Skin Care Cosmetic.

Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Skin Care Cosmetic by Regions (2014-2019).

Chapter 6: Skin Care Cosmetic Production, Consumption, Export and Import by Regions (2014-2019).

Chapter 7: Skin Care Cosmetic Market Status and SWOT Analysis by Regions.

Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Skin Care Cosmetic.

Chapter 9: Skin Care Cosmetic Market Analysis and Forecast by Type and Application (2019-2024).

Chapter 10: Market Analysis and Forecast by Regions (2019-2024).

Chapter 11: Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.

Chapter 12: Market Conclusion of the Whole Report.

Chapter 13: Appendix Such as Methodology and Data Resources of This Research.

Some Point of Table of Content:

Chapter One: Skin Care Cosmetic Introduction and Market Overview

Chapter Two: Industry Chain Analysis

Chapter Three: Global Skin Care Cosmetic Market, by Type

Chapter Four: Skin Care Cosmetic Market, by Application

Chapter Five: Global Skin Care Cosmetic Production, Value ($) by Region (2014-2019)

Chapter Six: Global Skin Care Cosmetic Production, Consumption, Export, Import by Regions (2014-2019)

Chapter Seven: Global Skin Care Cosmetic Market Status and SWOT Analysis by Regions

Chapter Eight: Competitive Landscape

Chapter Nine: Global Skin Care Cosmetic Market Analysis and Forecast by Type and Application

Chapter Ten: Skin Care Cosmetic Market Analysis and Forecast by Region

Chapter Eleven: New Project Feasibility Analysis

Chapter Twelve: Research Finding and Conclusion

Chapter Thirteen: Appendix continued

List of tablesList of Tables and FiguresFigure Product Picture of Skin Care CosmeticTable Product Specification of Skin Care CosmeticFigure Market Concentration Ratio and Market Maturity Analysis of Skin Care CosmeticFigure Global Skin Care Cosmetic Value ($) and Growth Rate from 2014-2024Table Different Types of Skin Care CosmeticFigure Global Skin Care Cosmetic Value ($) Segment by Type from 2014-2019Figure Sensitive Skin Care PictureFigure Dry Skin Care PictureFigure Infants Skin Care PictureFigure Others PictureTable Different Applications of Skin Care CosmeticFigure Global Skin Care Cosmetic Value ($) Segment by Applications from 2014-2019Figure Stem Cells Protection Against UV PictureFigure Flakiness Reduction PictureFigure Rehydrate the Skin Surface PictureFigure Minimize wrinkles PictureFigure Increase the viscosity of Aqueous PictureTable Research Regions of Skin Care CosmeticFigure North America Skin Care Cosmetic Production Value ($) and Growth Rate (2014-2019)Figure Europe Skin Care Cosmetic Production Value ($) and Growth Rate (2014-2019)Table China Skin Care Cosmetic Production Value ($) and Growth Rate (2014-2019)Table Japan Skin Care Cosmetic Production Value ($) and Growth Rate (2014-2019)continued

If you have any special requirements, please let us know and we will offer you the report as you want.

About Us:Analytical Research Cognizance (ARC)is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential.ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

Contact Us:Ranjeet DengaleDirector SalesAnalytical Research Cognizance+1 (646) 403-4695, +91 90967 44448Email: [emailprotected]

NOTE: Our report does take into account the impact of coronavirus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

Excerpt from:
Impact Of COVID-19 On Skin Care Cosmetic Market 2020 Industry Challenges, Business Overview And Forecast Research Study 2024 - Owned

Spin the wheel of glowy celebrity complexions youd like to emulate and wherever it lands, chances are Joanna Czech had something to do with it. With 30 years of experience as an esthetician under her belt, her facials are some of the most sought-after in the industry, and her intel is the stuff that beauty editors cling to like gospel. Shes schooled us in the benefits of enzymes for acne, and taught us why we should never, ever use thick moisturizers during the summer months, and our skin is much better for it.

As someone with a breadth of skin knowledge, its no surprise that Czech takes her own skin-care practices very, very seriously. I have reactive, dehydrated skin, which has gotten more dehydrated from loss of estrogen because of my age, says Czech, who also has stage one rosacea that is exacerbated by heat, stress, and certain foods. My skin doesnt do great with heat, needling, or deep exfoliation. I am all about supporting it with super hydrating, comforting, healing treatments and products.

As a special treat, she gave us a peak inside of her spring and summer season skin-care arsenal, and revealed what she uses on her skin every night. While her morning routine is chock full of nourishing products (and SPF, of course), she considers her evening regimen to be the most important, because skin at rest absorbs products better, so the efficacy increases. Read on for every product that graces her skin.

Post-cleanse, Czech balances her skin with P50. Its made with a combination of chemically exfoliating acids, which melt away dead skin cells and create a clean canvas on which to apply the rest of her routine. While the original P50 is pretty much the gold standard as far acid toners go, this formula has added benefits of helping with hyperpigmentation.

Massage is such an important step, as it speeds up circulation, bringing more oxygen to the tissue, resulting in brighter, healthier skin, says Czech. It can also change the shape of the face, lifting the brows, the jawline and emphasizing the cheekbones. Shes a fan of her namesake massage roller, which is made with two metal balls that de-puff your face while stimulating your skin. Pro tip? Put itor whatever roller youve got at homein the fridge or freezer for a luxurious cooling facial.

Czech changes up her routine seasonally, but right now shes currently slathering on this stem-cell infused serum. Its made with patented Bio-Cellular Technology that smooths and firms skin while helping to minimize fine lines and increase suppleness. Its also got hyaluronic acid to aid in hydration while you sleep. As far as application goes, shes a fan of the press and release motion. I spread the product on my skin and then press and release. Skin absorbs the product better, she says. And according to Czech, the best way to get your serums working over timewhether they cost $155 or $15is with a completely free hack. I make my own ice cubes from teaeither chamomile, green or blackand I run the cubes over my face after serum application, she says. This helps to seal in the product, and ensure its doing its job at max capacity while you sleep.

This moisturizer might just be the smartest on the market, and Czech co-signs its efficacy. It gives your body the building blocks it needs to create new cells, through amino acids, vitamins, and nutrients, which helps to improve the appearance of dark spots and acne scarring, while diminishing fine lines and wrinkles, and restoring elasticity. At $170 a bottle, its hardly a budget buy, but its so effective it might just replace every other serum in your routine.

To up the effectiveness of her go-to eye cream, Czech infuses it with a drop of Protective Nourishment Eye Glow Serum ($89). The cream helps to lift the eye and even out the tone of dark circles, while the serum helps to minimize fine lines and puffiness.

Keep lips hydrated all dayand all night with this balm, which is made with nourishing ingredients like glycerin and castor oil. In addition to fighting off chapped lips, it can also be used to treat dryness all over your body, from your elbows to your knees to your nails.

Want to know what a dermatologist uses in *her* routine? Check out the video below.

Our editors independently select these products. Making a purchase through our links may earn Well+Good a commission.

Here is the original post:
Ive Been an Esthetician for 30 YearsThis Is What I Do to My Skin Every Single Night - Well+Good

The research team includes (from left) Victoria Neckles, David Feliciano, Tori Riley, Aidan Sokolov and Jennie Holmberg.Image Credit: College of Science

CLEMSON, South Carolina College of Science associate professor and researcher David Feliciano has received a $667,000 grant from the Department of Defense to explore the cellular underpinnings of Tuberous Sclerosis Complex (TSC), a developmental disorder characterized by the growth of benign tumors throughout the body, most notably in the brain.

Young children with TSCoften have seizures, learning disabilities, behavioral issues, and a high rate of autism. A hallmark of the disorder is the presence of growths in the brain called subependymal giant cell astrocytomas (SEGAs). SEGAs can block cerebrospinal fluid flow resulting in hydrocephalus, behavioral changes, nausea, headaches, seizures, and are a cause of mortality. SEGAs can be surgically removed, however, their presence in infancy usually precludes immediate removal. Early intervention improves prognosis.

About a third of the TSC cases are inherited from a parent, while about two thirds of cases arise during in utero development, said Feliciano, of biological sciences. There are clues leading to a TSC diagnosis. For example, an infant may have seizures characterized by a head bobbing motion that almost looks like he or she is nodding off, skin lesions, and red bumps comprised of blood vessels on the face, especially on the nose and cheeks.

According to Feliciano, scientists know that TSC occurs because of a mutation on either the TSC1 or TSC2 gene. These genes normally produce proteins that stop cell growth via the mammalian target of rapamycin (mTOR) pathway. However, TSC1 or TSC2 mutations result in excessive mTOR activity and cell growth.

Coronal section of a mouse brain olfactory bulb genetically modified by in vivo neural stem cell electroporation (blue, old neurons; cyan, young neurons; magenta, nuclei of all cells).Image Credit: Courtesy of Victoria Riley

In the course of the three-year project, Feliciano will generate a novel mouse model of TSC, characterize the molecular pathways in this model, and test two potential drug therapies to evaluate their effectiveness on treating these harmful SEGAs.

The model will have mutations engineered in the neural stem cells of newborn mice. When these stem cells divide, the cellular progeny will be deficient in the Tsc2 gene, mimicking the human disease. These mice will also express an inducible fluorescent protein allowing the altered cells to be tracked by microscopy.

Well be able to closely examine how the SEGAs form in this model, Feliciano said. We can examine the cell types and cellular processes that are altered, and we can study how the biochemical pathways are altered within the SEGA cells.

While we have developed other models of TSC, none to date fully recapitulate SEGAs, Feliciano added. Having a SEGA model is important because it allows one to interrogate the molecular pathways and identify mechanisms of pathogenesis. In the final step of the project, Feliciano will test the effectiveness of two potential therapies which may stop the formation of SEGAs.

TSC is a relatively rare disorder, occurring in one out of every 6,000 births. TSC provides a framework to understand the pathways that orchestrate normal brain development. Many other diseases are also characterized by changes to the same pathways, although the causative genes are unknown. Therefore, the results of this research will be applicable to additional diseases, said Feliciano, citing cancer and epilepsy as two examples.

This research is supported by the Department of Defense Award Number W81XWH-19-TSCRP-IDA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the DoD.

See the article here:
Feliciano receives $667K DOD grant to explore developmental disorder that causes tumors in the body and brain - Clemson Newsstand

ONE simple act could save this little girl's life.

Little Shahera Khan has a fault with her immune system that means her body can't produce enough white blood cells.

3

It means the toddler is susceptible to infections, meaning a seemingly innocuous bug could kill her.

Shahera's life is very different to those of other tot's her age.

She can't go to nursery, make friends or really interact with too many other kids, for fear of picking up infections.

While she loves to play with her big brother, Amaan, five, she has to take daily medication and has blood transfusions each week.

If she picks up a common cold or cough, it can leave her in hospital for days while her tiny body fights the bacteria or virus.

Now, her parents are pleading for help from strangers, to offer their little girl a chance at a normal life.

Shahera's only hope of growing up like her peers is a stem cell transplant.

Speaking to The Sun her Mum Amina said she just wants her daughter to get better and to lead a normal life.

Shahera was born a healthy child and she was okay when she was small.

She picked up bronchiolitis when she was eight months old and had to be hospitalised. We were there for a week and she also picked up an ear and nose infection.

A lot of people say she has been through the wars and she has, she hasnt had an easy childhood and theres always something new with her illness

Amina, who lives in Croydon with Shahera, her husband and Sharehas little brother said that she had Shahera at home for just a couple of days before she had to go back to hospital due to coughing fits.

She recovered at home but within two weeks the family were sent a letter that detailed she had low immunity.

Amina said that little Shahera had a rash on her face and said doctors then had to do a biopsy.

They were scratching their heads really. After a biopsy they found that she was an unusual case.

3

Her skin was pretty bad at that point and they gave her steroids and antibiotics.

At the Evelina hospital they ran further tests on Shahera, but sadly she then had to be hospitalised for bacterial sepsis.

Amina said that all of this happened during the 2018 World Cup and said she remembers it so well as temperatures were soaring and she was trying to control little Shaheras temperature.

She was so thirsty and her temperature was 38/39C.

How to join the stem cell register

Little Shahera needs a stem cell donor - here's how you can register

You can join the stem cell register online. All you need to do is fill out a registration form and you will be sent out some swabs.

You will need to take some samples, usually from the inside of your mouth and then send them back. As soon as they are received you'll be added to the register.

You'll remain on the register until you are 61-years-old.

If you are a match for someone in need charities such as Anthony Nolan will help guide you through the process.

Around 90 per cent of people are able to donate via their blood stream with 10 per cent donating from bone marrow while under general anaesthetic.

To find out more and to register you can visit the below sites:

Then the hospital found that one of her white blood cells was completely wiped out, she was very sick and it was at that point that the doctors mentioned a bone marrow transplant.

Once again Shahera was allowed to return home and she made a good recovery.

Then when she was just one her rash appeared again and more tests found that she had a rare immunodeficiency.

Shahera now has antibody immunoglobulin treatments every week and Amina said this makes a big difference to her quality of life.

3

The issue now Amina says, is that doctors need to find a way to continue to treat Shahera so she can do all the things that other little girls can.

Doctors have given the family several months to find a donor and have said the transplant could take place as early as next spring.

Finding a donor though will be a struggle for the family as just 20 per cent of patients from BAME backgrounds find the best possible donor match.

This is in comparison to 69 per cent for people with white European heritage.

Finding a donor would be a big relief for us, because hopefully it will maker her better

Shahera is of Bangladeshi origin and Amina said its difficult for the family to find someone from their community.

We are part of her journey and it has been difficult but we have been very patient and we are still working with consultants and professors.

At the moment she is doing as well as she can be and she has been shielding due to Covid-19.

Finding a donor would be a big relief for us, because hopefully it will maker her better.

Amina said that the family are not only campaigning to find a donor for Shahera but for others in the same situation.

What is immunoglobulin therapy?

Little Shahera has to have antibody immunoglobulin treatments to keep her well

It is a blood-based treatment that contains antibodies in order to fight against infections.

People are given this treatment when their immune systems do not produce enough antibodies.

Some patients are at a higher risk than others.

Charity PID UK states: "Clinical trials have shown that for people with immune deficiency, immunoglobulin treatments result in fewer infections, and those infections that do occur tend to be less serious.

"There is also evidence that people with immune deficiency are more likely to enjoy good health over many years if they receive immunoglobulin correctly. Finally, your wellbeing and your energy levels are likely to be better if you are on immunoglobulin.

"It may take several months before you feel these benefits.

Everything has been put on hold because of Covid but donating is such a simple process.

A lot of people have misconceptions about stem cell donation, but donors can save lives.

Due to the coronavirus lockdown little Shahera has spent lots of quality time with her family.

Amina said she is doing well and has enjoyed spending even more time with her older brother.

She likes to play cops and robbers and fireman Sam but she also enjoys doing girly things too like looking after her dolls.

Now that Shahera is a little bit older, Amina said she is more aware of her rash and will sometimes look at it and point.

She is very aware of the transfusions and understands what is happening and she is very well known in the ward.

She doesnt really cry when they prepare her for transfusions.

A lot of people say she has been through the wars and she has, she hasnt had an easy childhood and theres always something new with her illness.

Exclusive

FUN IN THE SUNBrits holidaying on Costa Del Sol say they feel much safer in Spain than UK

FEAR & LOATHINGDepp calls Heard a 'calculating sociopath' as she says he beat her in rages

DEPP DIVORCE Johnny Depp 'divorced Amber Heard after she POOED in their marital bed'

Comment

ARTHUR EDWARDSPrince Harry's lost the plot to slam the Queen's beloved Commonwealth 'club'

KIDS ARE ALL RIGHTWages of under-25s to be subsidised in Sunak scheme help 350k find jobs

Warning

HES TRAUMATISEDBoy, 2, has face ripped in half by Staffie that tried to snatch food

But shes a tough little girl and she is doing really well.

Sarah Rogers, register development manager at Anthony Nolan says: Little Shahera wants to go to nursery, learn and make more friends just like other toddlers olds across the UK. For this to happen she needs a stranger to donate their stem cells.

"If youre aged 16-30 you can join the register online and well send you a cheek swab in the post.

"If youre found to be a match for a patient, you could donate your stem cells and give hope to families like Shaheras. Your support could help us give a patient, their family and their friends a second chance of life."

Continued here:
One common infection could kill our baby girl but one simple act could change her life forever - The Sun

A man undergoes a rapid HIV test. (CLAUDIO REYES/AFP via Getty)

In a major leap forward in the search for a HIV/AIDS cure, a person has been cured of HIV using a cocktail of medicines in what activists have dubbed a breakthrough as exciting as it was unexpected.

HIV, known as human immunodeficiency virus, hobbles peoples immune systems leaving them more vulnerable to once everyday diseases.

In a new study, presented Tuesday (July 7) at the International AIDS conference 2020, a patient on a relatively simple antiretroviral drugregimen was given a medicine commonly used to treat skin cancer.

Previous milestones of individuals HIV appearing to go into long-term remission resulted from bone-marrow transplants given to infected patients. Similarly, the transplants were intended to treat cancer in the patients, not HIV.

But bone-marrow transplants on top of being costly are unlikely to be realistic or reliable treatment options and are, at times, riddled with risk. Yet, this case involved no invasive medical procedures.

As a result, experts told PinkNews, while they are wearily calling it a cure for the virus, it is difficult how to define the word when instances of the virus demise are so few.

Moreover, they said, caution must be exercised in pivoting the case as a success, as scientists must assess whether the outcome can be replicated.

And while the HIV epidemic continues, advocates have warned that the emergence of the coronavirus pandemic its continually sweeping infection rates and how it is vacuuming the attention of scientists and healthcare officials will no doubt knock back success made in recent years.

Dr Andrea Savarino, of the Instituto Superiore di Sanit in Rome, Italy, explained to HIV advocacy group aidsmap during a video call seen by PinkNews that the patient, one of five, was given an experimental drug commonly used as a skin cancer preventative called Nicotinamide as part of the study.

The medicine boosts the immune system, and some academics have demonstrated how Nicotinamide inhibits advanced stages of HIVinfection in cell culture and works on multiple mechanisms to reel back HIV, Savarino said.

By the end of the study, Savarino said, a common indicator of the virus presence viral DNA was undetectable in the patient. Savarino admitted this was not an optimal marker, but it may give an indication of the size of the viral reservoir.

Researchers have long struggled to find a way to destroy HIV reservoirs clusters of infected immune cells that are not producing new HIV but this strategy, Savarino explained, may provide a possible blueprint.

Even after the patient was taken off of his antiretrovirals treatments, the virus did not rebound, the viral DNA was maintained negative, he said. The antibody response decreased over time, if the antibody decreases, it is possible that the virus has stopped its repetition.

The other four patients did rebound, the researcher said.

He stressed that the antibodies made to fight HIV have not disappeared altogether, but did decrease hes still being monitored in order to understand whether the antibodies might disappear as in the case of Mr Timothy Brown,Savarino added.

Brown, often referred to as the Berlin patient, beat HIV with a combination of stem cell transplants and radiotherapy following a diagnosis of leukaemia.

During the trial, only mild side-effects were observed from the cocktail of medicines: No real side-effects were observed from Nicotinamide, which was in-line with previous trials of the medicines impact on cancer.

However, the HIV expert stressed that those living with HIV should not take Nicotinamide in a non-medical setting, being that it is a potent and still experimental medicine.

I really hope that [the study] boosts further research into a HIV cure because it is the first time such a condition is seen, to my knowledge, in a patient under chronic HIV infection, and without having been subjected to a life-threatening medical procedure such as bone marrow transplant, he said.

However, this is our very first experiment, and I wouldnt foresee beyond that.

This was an unexpected result its proof of a concept that we werent really looking out for, Matthew Hodson, executive director of aidsmap, told PinkNews.

We have had effective treatment for HIV for 34 years but 690,000 people died of AIDS last year.

We anticipate that due to COVIDs disruption of health services there will be an even greater number of AIDS-related deaths this year. People around the world are desperately in need of a cure and this case does give us renewed hope.

Although the news is exciting, at this point we have to proceed with caution. We know that a very small number of people can achieve what appears to be remission with antiretroviral drugs alone and it remains possible that this is the case here.

We need to know whether this finding will be replicated in other people, especially as it was not replicated in four other people on the trial.

This particular treatment is relatively inexpensive and, unlike the bone marrow transplant that resulted in previous cure cases, is not especially dangerous to the patient.

This gives me hope that it could be rolled out widely if we found it to work in other people.

Only one person in the small group given this treatment seems to be cured.

Further trials are necessary to find out whether it works for others and which part of the treatment made the difference. This means that it will be some years yet before this treatment will be accessible.

The global fight against AIDS was staggering even before the COVID-19 pandemic, activists admitted, as the United Nations said Sunday that global HIV targets will not be reached.

The organisations AIDS agency said in a report that COVID-19 may hurl progress against the virus back by a decade or even more.

Data from 2019 shows that more than 38 million people worldwide have acquired HIV a million more than in 2018.

UN officials noted that while some 25.7 million people living with HIV were on antiretroviral treatment in 2019 a feat unimaginable a decade prior it still leaves12.6 million not on the life-saving medications.

Here is the original post:
History made as first person ever is 'cured' of HIV using medication alone - PinkNews

From Netdoctor

Lymphoma, a type of blood cancer, is the fifth most common cancer in the UK. Lymphomas can be hard to diagnose and with sixty different types, the treatments vary hugely from a watch and wait option to intensive chemotherapy, radiotherapy and even stem cell transplants. People can live for many years with lymphomas so lets look at how they present and what the treatment options are.

Lymphoma is a cancer of lymphocyte cells. Lymphocytes are one of our white blood cells and they play an important role in helping our body to fight off infection. They are present in lymph fluid which circulates around the body via a network of lymph nodes and lymph vessels which form the lymphatic system.

It is common for lymph nodes (also called lymph glands) to swell up when you have an infection. For example, you may notice swollen glands in your neck when you have a sore throat. The glands shrink back down again as the infection clears.

In lymphoma, something happens to the DNA of the lymphocytes which results in the lymphocytes behaving abnormally, they reproduce and multiply in an uncontrolled way. Large numbers of lymphocytes mean that the lymph nodes become congested and swollen without the presence of infection.

There are different type of lymphocyte cells and around sixty different types of lymphoma but they can be divided into two groups:

Non-Hodgkin can be further divided into:

People of any age can get lymphoma, including children. Hodgkin lymphoma occurs most commonly in people in their early twenties and in the over seventies. It affects around 2,000 people each year in the UK. Non-Hodgkin lymphoma is more common affecting around 14,000 people each year, a third of whom are over the age of 75.

The causes of lymphoma are largely unknown. There may be an inherited genetic mutation which causes the DNA to wrongly instruct the lymphocytes to multiply but its not known for certain if lymphoma runs in families.

Whilst it doesnt point to the cause, certain people are at higher risk of developing lymphoma. These include people who have a suppressed immune system. The suppression may come from the presence of a medical condition which directly affects the immune system such as HIV or from taking an immune suppressing medication. People who have previously been infected by the Epstein Barr virus (responsible for glandular fever) also seem to be at higher risk of lymphoma.

Because some of the symptoms of lymphoma such as swollen nodes and fatigue are common, it can be hard to diagnose lymphoma. Superficial lymph nodes in the neck and armpits are easy to feel but many nodes lie deep within the chest or abdomen and cant be seen or felt.

The most common symptoms of lymphoma are:

These are most commonly in the neck, armpits and groin area. Smooth, rubbery lumps can be felt. They arent usually painful and gradually enlarge although they may go up and down in a low grade, non-Hodgkin lymphoma.

If you have swollen glands that have persisted for over two to three weeks or are getting progressively bigger, then see your doctor.

Photo credit: Christopher Futcher - Getty Images

The following generalised symptoms, also called systemic symptoms may be present:

Story continues

When lymph nodes become enlarged they can press on the body tissues surrounding them resulting in a variety of symptoms depending on the location of the nodes. These include:

Some people may have only one symptom, whereas others will have multiple. Similarly, some people may become rapidly very unwell whilst others have a slower, milder form of lymphoma. The variety is huge due to the many different types and locations of lymphoma.

When you feel unwell or notice swollen glands, your first contact is usually with your GP. He or she will not be able to make a diagnosis of lymphoma but may have suspicions based on listening to your explanation of your symptoms and after examining you.

Blood tests will usually be ordered. These include a Full Blood Count (FBC) which gives details of the number of white blood cells, including lymphocytes in your blood. It cannot however give a diagnosis of lymphoma. To reach this you will be referred to a specialist who will arrange specific tests to not only confirm lymphoma but also to work out how advanced the lymphoma is. These include a biopsy where a sample of the tissue from a gland (or commonly a whole gland) is removed and examined under the microscope. Scans such as CT scans, ultrasound scans and X-rays all help to diagnose lymphoma and determine the best treatment plan.

Once the diagnosis has been made, the doctor will find out what stage the lymphoma is at. This means working out which parts of the body are affected and how advanced the disease is. Staging helps to plan the right treatment.

The following staging is for adults with Hodgkin and non-Hodgkin lymphoma. The staging is different in children

Stage 1 only one group of lymph nodes is affected

Stage 2 two groups of lymph nodes are affected but they are both on the same side of the diaphragm e.g. in the neck and armpit

Stage 3 Lymph nodes on both sides of the diaphragm are affected e.g. neck, armpit and groin

Stage 4 Lymphoma has spread to organs outside of the lymphatic system e.g. lungs, liver

Photo credit: Peathegee Inc - Getty Images

The treatment plan for lymphoma varies according to the type and stage of lymphoma however factors such as age, other medical conditions and general health can influence how effective and well tolerated treatment is.

Treatment plans are usually drawn up after a Multi-Disciplinary Team meeting. This is a discussion between a collection of specialists who all use their expertise and previous experience to determine the best course of action for each individual patient.

The aim of treatment is to push the lymphoma into complete remission where there is no evidence that it is still present in the body and to prevent relapses. Sometimes where the lymphoma is a low grade, non-Hodgkin type, the aim is for a partial remission, quietening the disease. In this situation, sometimes treatment isnt offered immediately and a watch and wait approach is taken.

Treatment options include:

The charity Lymphoma action states, In the UK, no alternative therapies are registered for the treatment of lymphoma. There is no evidence that they are effective and they are not recommended by the NHS. Although not recommended as a treatment, many patients gain benefit from complementary therapies alongside their medical treatment. Therapies such as massage, aromatherapy, meditation and mindfulness, can all help to lower stress and anxiety and improve wellbeing and quality of life.

Most cases of lymphoma are treatable.

In England, approximately 75 per cent of people with Hodgkin lymphoma will survive for ten years or more. Younger people and those who are diagnosed earliest have the best survival rates.

The survival rate for non-Hodgkin lymphoma has tripled in the last 40 years in the UK and almost two thirds of people will survive beyond ten years. The survival rates are highest in young people and 9 in 10 people diagnosed with non-Hodgkin lymphoma between the ages of 15 and 39 will survive for more than five years.

*stats from Cancer Research UK https://www.cancerresearchuk.org

Lymphoma action

Blood Cancer UK

Last medically reviewed: 08-07-2020

You Might Also Like

Here is the original post:
What is lymphoma? Symptoms, causes and diagnosis - Yahoo Lifestyle UK

Cosmetic Skin CareMarketBusiness Insights and Updates:

The latest Marketreport by a Data Bridge Market Researchwith the title[Global Cosmetic Skin CareMarket Industry Trends and Forecast to 2026].The new report on the worldwide Cosmetic Skin CareMarketis committed to fulfilling the necessities of the clients by giving them thorough insights into the Market. The various providers involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.The reports provide Insightful information to the clients enhancing their basic leadership capacity identified.Exclusive information offered in this report is collected by analysis and trade consultants.

Global cosmetic skin care market is set to witness a substantial CAGR of 5.5% in the forecast period of 2019- 2026.

Cosmetic skin care is a variety of products which are used to improve the skins appearance and alleviate skin conditions. It consists different products such as anti- aging cosmetic products, sensitive skin care products, anti- scar solution products, warts removal products, infant skin care products and other. They contain various ingredients which are beneficial for the skin such as phytochemicals, vitamins, essential oils, and other. Their main function is to make the skin healthy and repair the skin damages.Get PDF Samplecopy(including TOC, Tables, and Figures) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-cosmetic-skin-care-market

Thestudy considers the Cosmetic Skin CareMarketvalue and volume generated from the sales of the following segments:Major Marketmanufacturerscovered in the Cosmetic Skin CareMarketare:LOral, Unilever, New Avon Company, Este Lauder Companies, Espa, Kao Corporation, Johnson & Johnson Services, Inc., Procter & Gamble, Beiersdorf, THE BODY SHOP INTERNATIONAL LIMITED, Shiseido Co.,Ltd., Coty Inc., Bo International, A One Cosmetics Products, Lancme, Clinique Laboratories, llc., Galderma Laboratories, L.P., AVON Beauty Products India Pvt Ltd, Nutriglow Cosmetics Pvt. Ltd, Shree Cosmetics Ltd

By Product

By Application

By Gender

By Distribution Channel

Get Table of Contents with Charts, Figures & Tables @https://www.databridgemarketresearch.com/toc/?dbmr=global-cosmetic-skin-care-market

Based on regions, the Cosmetic Skin CareMarketis classified into North America, Europe, Asia- Pacific, Middle East & Africa, and Latin AmericaMiddle East and Africa (GCC Countries and Egypt)North America (United States, Mexico, and Canada)South America(Brazil, Argentina etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Market Drivers:

Market Restraints:

Key Developments in the Market:

Key Benefits for Cosmetic Skin CareMarket:

Enquire Here For Discount Or Cosmetic Skin CareMarket Report Customization@https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cosmetic-skin-care-market

About Us:Data Bridge Marketresearch endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process Data Bridge set forth itself as an unconventional and neoteric Marketresearch and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Marketopportunities and foster efficient information for your business to thrive in the Market.We ponder into the heterogeneous Markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the Markettrends. Data Bridge delves into the Markets across Asia, North America, South America, Africa to name few.

Contact Us:Data Bridge MarketResearchUS: +1-888-387-2818UK: +44 208 089 1725Hong Kong: +852 819+2 7475Email: [emailprotected]

See the article here:
Global Cosmetic Skin Care Market Updates, Future Growth, Business Prospects, Forthcoming Developments by Forecast to 2026 - 3rd Watch News

Dr. Taz Bhatia, an immune support and wellness physician, offers seven tips parents can follow to help keep their kids healthy:

Add foods high in vitamin C:

Citrus fruits and vegetables rich in vitamin C like: oranges, grapefruits and beets support and help build a strong immune system. With children, we really want them to get their vitamins through food, so the earlier you can establish some of these healthy eating habits, the better for their overall health, Bhatia says.

Make chicken soup a weekly option:

Another immune-supporting food for kids is chicken soup. It isnt just an option when children are sick. Its a great food to bring in maybe a couple of times a week to keep the immune system primed and supportive, she explains. Chicken soup produces collagen that helps keep skin, hair and bones strong. It also has antiviral and antibacterial properties.

Check out the video above for more tips.

TAZ BHATIA: Hi, there. It's Dr Taz again, and if you're like me, you're worried about keeping your children healthy. Well, here are some foods and habits to keep your children's immune system right where it needs to be.

We know that high-vitamin-C foods, especially our citrus fruits like oranges, grapefruit, and vegetables like beets have tons of vitamin C in it that really support and help the immune system. With children, we really want them to get their vitamins through food, so the earlier you can establish some of these healthy eating habits, the better for their overall health.

Another immune-supporting food for kids is chicken soup. Chicken soup actually produces collagens and other amino modulators that keep the immune system primed and actually act as an antiviral and an antibacterial.

My next tip is all about sugar. Are they drinking too many sweet drinks, too any juices in a given day? And how much of their sugar is refined sugar or sugar from convenience foods or packaged foods versus natural sugars that we find in things like fruits? The more we can lower sugar, the healthier they will be.

Story continues

Aromatherapy is also beneficial for our kids, and it's really easy. Rosemary, eucalyptus, and even tea-tree oil are some of my favorite oils to use in children. You typically want to rub them on their wrist, maybe on the sides of the nose, or you can diffuse them or they can steam with them to help get all the therapeutic benefits of these essential oils.

We know that most children need about 10 hours sleep a night. That's 10 hours of continuous sleep. The younger ones need 12 hours, and even those teenagers and adolescents, they shouldn't be skimping below 10.

Children need exercise probably even more than adults do. The daily dose is critical for the immune system. We know that when they're active, when they're running around, it also helps to produce chemicals, cytokines, that support the immune system rather than fight against it.

Teaching children to wash their hands has now, more than ever, become so important. So teaching your children some of these habits to where it becomes routine is going to help them as we come out of this pandemic.

Read the original:
Foods and habits that can help strengthen your child's immune system - Yahoo Lifestyle

More than a third of Americans arent getting enough sleep, according to the Centres for Disease Control and Prevention.

For optimal health, adults need at least seven hours of sleep each night. But depending on your age, you might need even more:

If you consistently lack sleep, it can pose serious health risks. In the short-term, staying awake for 17 to 19 hours straight can impair your reaction time as much as a blood-alcohol level of 0.05%, which is considered legally drunk. Long-term, a consistent lack of sleep may also increase your likelihood for a heart attack or mental illness.

Here are 6 ways a lack of sleep can negatively impact your health:

Insufficient sleep can affect your mood and increase your stress levels.

In fact, people with insomnia are 17 times more likely to develop clinical anxiety than people who arent sleep deprived. Non-depressed people who have insomnia may be twice as likely to develop depression than people who sleep well.

This could be due to the impact that a lack of sleep has on the brains ability to regulate emotions, which can lead to mood disturbances and negative thinking.

For example, a study published in Current Biology in 2007 examined healthy participants who were deprived of sleep for 35 hours. When the sleep deprived patients were shown negative images, they had more activity in the amygdala the area of the brain that regulates emotions and anxiety levels than participants who werent sleep deprived.

In addition, research has found that 65% to 90% of adults with depression have sleep problems. While a lack of sleep can affect your mental health, depression can also cause insomnia, leading to a vicious cycle.

Researchers have found that just five hours of lost sleep in a 24-hour period can cut off the connection between neurons in the hippocampus, the area of the brain associated with memory.

In one small study published in the journal Neuroscience in 2005, 12 healthy college-aged participants were taught a sequence of finger movements and asked to repeat it 12 hours later as an MRI measured their brain waves.

Researchers found that the cerebellum, the area of the brain that controls accuracy, was more active in participants who had slept during that time period. This suggests that while you sleep, memory is shifted to more efficient storage areas in the brain.

A lack of sleep may also impair the brains ability to flush out beta-amyloid, a toxic protein in the fluid between brain cells that has been linked to memory loss and Alzheimers disease.

Not sleeping enough at night will make it more difficult for you to learn or remember things later, says Raman Malhotra, MD, a sleep medicine physician and associate professor of neurology at Washington University School of Medicine. Sleep helps imprint memories or things you are studying to try and remember in the future.

Not getting seven to eight hours of sleep each night can activate your bodys endocannabinoid (eCB) system, which increases your appetite for pleasurable but unhealthy foods, like candy and chips.

In one small study of 14 healthy young adults, published in the journal Sleep in 2016, researchers found that participants who got insufficient sleep for four nights had higher eCB levels in the afternoons than those who got a good nights sleep. The elevated eCB levels increased their appetites and their cravings for snacks.

It can increase your urge to eat by altering the normal release and levels of different hormones responsible for hunger and satiety, Malhotra says. Research has also found that a lack of sleep increases the release of ghrelin, the hormone that stimulates your appetite, and decreases the release of leptin, the hormone that makes you feel full.

In addition, if youre not getting enough sleep, you may feel fatigue and not have the energy to exercise regularly, which can also contribute to weight gain. A small study of 15 healthy men, published in the American Journal of Clinical Nutrition in 2009, found that fewer hours of sleep for two nights in a row resulted in significantly decreased daytime physical activity.

Getting less than seven hours of sleep each night can increase your risk of heart disease, heart attack, or stroke regardless of your age, weight, and whether or not you smoke or exercise, according to the National Sleep Foundation.

High blood pressure, or hypertension, is one of the major risk factors for heart disease. While youre getting a good nights sleep, your blood pressure should decrease about 10% to 20%, which is known as nocturnal dipping. But if you dont get the sleep you need, your blood pressure wont dip at night and research has found that even small increases in your nighttime blood pressure level can lead to an increased risk of heart disease.

A consistent lack of sleep can also affect your bodys ability to regulate stress hormones, and this chronic stress may contribute to a heart attack over time.

In 2017, there were an estimated 91,000 police-reported car crashes involving drowsy drivers in the US about 50,000 people were injured and nearly 800 were killed.

Driving while drowsy is similar to driving under the influence. It slows down your reaction time and awareness of hazards, and reduces your ability to pay attention to what youre doing.

According to a study published in the journal Sleep in 2018, drivers who had fewer than four hours of sleep in the preceding 24-hour period were 15.1 times more likely to be responsible for a car crash than drivers who slept seven to nine hours during the same period.

Many work-related accidents are also attributable to insufficient sleep. Sleep-deprived workers are 70% more likely to have accidents on the job and twice as likely to die from those accidents than well-rested workers.

A lack of sleep can also result in poor judgment. This may be because sleep deprivation affects your brains prefrontal cortex, the area that controls logical thinking. Examples include:

Sleep deprivation might also affect your moral judgment, because it impairs your brains ability to use emotion and cognition to help you make decisions. Examples include:

The adverse health effects of a single sleepless night can usually be mediated if you get better consistent sleep over the next few nights, Malhotra says. However, if youve been experiencing a chronic lack of sleep over multiple weeks, months, or years, you may be at a great risk of health problems that are more difficult to reverse.

Some sleep disorders, like insomnia or sleep apnea, will require medical treatment in order to fully resolve your sleep issues. If you think you are not getting enough sleep, consult with a physician or sleep specialist who can discuss treatment options.

Site highlights each day to your inbox.

Follow Business Insider Australia on Facebook, Twitter, LinkedIn, and Instagram.

Here is the original post:
6 harmful effects of lack of sleep and why it's unhealthy - Business Insider Australia

Photo credit: The Cheesecake Factory

From Delish

The Cheesecake Factory is loved for its extensive menu, and while the insane amount of entrees available is impressive enough, it's the wild amount of cheesecake that really keeps people coming back. There are over 30 flavors with new ones always being introduced, including the latest: Chocolate Caramelicious Cheesecake made with Snickers.

Here at Delish we love a food mashup, so Snickers and cheesecake already seems like a perfect match. Just like the classic candy bar, this cheesecake is made with peanuts, caramel, nougat, and milk chocolate, so you're getting the same taste of a Snickers in a new, creative way.

The cheesecake starts off with a brownie crust and is made with original cheesecake swirled with Snickers so you'll get crunch in every bite. On top of the cheesecake is a layer of caramel and peanuts. Then, there's a layer of chocolate that is all topped with caramel and chocolate drizzle, chunks of Snickers, and heaping piles of whipped cream.

The Chocolate Caramelicious Cheesecake made with Snickers will be available at The Cheesecake Factory starting July 30. If you need more convincing that this Snickers cheesecake belongs in your life, ordering it will benefit a good cause. The Cheesecake Factory is donating $1 to Feeding America for each cheesecake ordered on July 30.

From there, for every slice of Snickers cheesecake ordered from July 31, 2020 to July 29, 2021, 25 cents will be donated to Feeding America, so this flavor really is the gift that keeps on giving.

You Might Also Like

Read more:
A New Cheesecake Is Coming To The Cheesecake Factory And Snickers Lovers Will Lose Their Minds For It - Yahoo Lifestyle

I have never been a fan of canned tuna. As a child, I would reach for the pimento cheese or slap together a quick PBJ anytime tuna salad was in the works. Tuna aside, though, I always have canned proteins on hand for quick meals: mackerel (definitely), Spam (anytime), sardines (into them), octopus (yes, octopus!). But some of these ingredients, perhaps, miss the most appealing aspect of cooking with canned tuna: affordability.

So when our former editor Rhoda Bonne introduced this recipe using budget-friendly canned salmona product I hadn't previously triedI was stoked. In it, Rhoda turns canned salmon into burger patties that she loads up with roasted red peppers and various other pantry staples. The burgers (which clock in at a bit over $2 each) are slightly sweet, salty, and rich, and since they're cooked in a pan on the stove, they're a great option if you're without a grill this summer.

You can also form the salmon mixture into smaller patties and tuck them into lettuce wraps, or pile them into rice bowls. These versions are especially good if you happen to have some ripe avocado and shaved radish to slide in there, too.

The salmon (at $4.68 for four servings) and red peppers are the most expensive part of these burgers, but there are a few ways to curb that cost, if you'd like. First, you could marinate your own peppers (buy them on sale and make a big batch to have on hand for salmon burgers, romesco, or one of these other 14 dinner ideas). Second, if you have leftover grilled, roasted, or poached salmon that you haven't factored into your meal plan already, this is a great opportunity to use it: just flake it up and let it take the place of the canned stuff. And finally, always toss the ends of bread or the crusts that the kids don't eat into the freezer and turn them into homemade breadcrumbs instead of buying the canister.

The Breakdown

Canned Salmon: $4.68, Lemon: $.89; Roasted Red Peppers: $.85; Mayonnaise: $.80; Hamburger Buns: $.48; Mustard Seeds: $.30; Capers: $.29; Breadcrumbs: $.16; Vegetable Oil: $.06; ; Total: $8.51 ($2.13 per serving). For more on how Epicurious prices out recipes, click here.

Story continues

Use It Up

The canned salmon is usually available in 14.75-ounce cans, but you'll need 18 ounces for four patties. You could use the remainder of the second can to make at least two more patties, if you'd like, bumping up the other ingredients accordingly; or you could flake the remaining salmon into your favorite canned tuna recipe. You'll also have four buns leftover from an eight-pack. I highly recommend turning them into breakfast sandwiches. As for those extra capers, this riff on puttanesca is a great way to make your pantry items earn their keep.

Originally Appeared on Epicurious

Go here to see the original:
A Budget-Friendly Canned Fish Dinner That Doesn't Rely on Tuna - Yahoo Lifestyle

Photo credit: Thinx

From Best Products

Managing your period can be a hassle that takes some trial and error to figure out, but we've found that Thinx Period Panties make the process a whole lot easier. From their full-bottom briefs to shape-flattering thongs, Thinx offers a wide array of underwear types that are perfect for that time of the month. Now you can add that extra security and comfort to your nighttime routine with Thinxs newest period-management product: Sleep Shorts.

At first glance, the Thinx Sleep Shorts might remind you of your favorite cozy pair that youd wear to bed or while lounging around your home. But what makes these shorts a period-management must-have are the built-in organic cotton Super Hiphugger undies that reach from the front all the way up your backside, offering you 360 degrees of leakage protection.

Designed with Thinx innovative technology that can securely hold up to four tampons worth of your flow about 36 milliliters you can easily replace your usual nighttime disposable period products. Made of luxuriously soft and comfortable micro-modal fabric, youll actually look forward to wearing them at bedtime instead of worrying about leaks throughout the night.

Lets be honest sleeping with thick, bulky pads can be very uncomfortable, and it limits your range of sleeping positions. Snoozing through 8 hours with a tampon can be both unreliable and highly questionable when it comes to vaginal health and wellness. Both options can lead to stain-causing leaks that are super tough to scrub out of your sheets, undies, and PJs. Thinx Sleep Shorts offer anyone who has periods the assuredness of ultimate, full-coverage protection during that pesky time of the month without compromising on comfort.

The shorts are available in black with white button accents as well as heather gray with black button accents, and range in sizes from extra-small to extra-large. The best part is that the shorts have actual, functioning pockets, which is obviously a must-have for proper lounging!

Story continues

For $50, you can get back to sleeping like a log, even when your Aunt Flo shows up for her monthly visit.

Read More:This Is the Best Underwear to Make Your Workout More Comfortable

Allbirds Just Launched Silky-Smooth Undies and You'll Want Them in Every Shade

Skims Boob Tape Is the Anti-Bra Hack That You Need This Summer

Follow BestProducts.com on Facebook, Instagram, Twitter, and Pinterest!

You Might Also Like

Read this article:
Thinx New Sleep Shorts Are Cute, Comfy, and Can Hold Up to Four Tampons Worth of Your Flow Without Leaking - Yahoo Lifestyle

Photo credit: Ben Watts

From Women's Health

Naomi Watts felt pretty good going into 2020. After spending the holidays in Australiawhere the 51-year-old actress spent part of her childhood and where some of her family still liveseating and drinking whatever her heart desired, she embarked on an anti-inflammation diet shes relied on numerous times in the past as a sort of reset. She cut out wheat, sugar, dairy, and alcohol. She worked out three to five times a week, alternating between boutique fitness classes, yoga, and personal-training sessions. After one month, she felt so good, she continued with the routine. She planned to keep it up through April, when she was due to start filming the first of three projects she had lined up for the year.

We all know what happened next. COVID came, and I was like, Nah, Im gonna have a glass of wine when I want, she says. Im stealing the kids Oreos. I never stop eating pasta. Were baking cakes, banana breadI dont ever want to see another piece of banana bread after this. She also started eating bacon again. I was closer to vegan before [this situation], she says.

Naomi has been homebound for six weeks when she FaceTimes me from Long Island, New York. Sitting in a directors chair, wearing a cream-colored sweatshirt, chunky-framed, cool-girl eyeglasses, and a blunt-cut bob, she looks every bit the leading woman in control. But shes the first to admit shes not, and shes fine with that.

These weeks have given the star of The Loudest Voice time to think about anxiety, uncertainty, and how to make the best of thingsthat is, when shes not homeschooling her children, Sasha, 13, and Samuel Kai, 11; cooking for the family; or finding ways to work with basically all film and television production shut down. All bets are off, she says, and I think thats just fine. Whatever you need to do, you do.

For Naomi, that means counterbalancing baked goods with sweat sessions, often in the form of The Class, an hour-long workout that merges calisthenics and plyometrics with a soundtrack of all-the-feels music and self-help guided instruction by creator Taryn Toomey. (Among Naomis fave messages: Start showing up. Breathe into yourself. What do you say when the road gets rough? When the sh*t hits the fan?) Taryn Toomey sometimes directs her students to shake their bodies and scream, to vocalize any tension they have stuck inside.

Story continues

Ive always liked to be physical, says Naomi, who grew up running and dancing. Im an active person. But I also love the outlet that Taryn creates. Its a get your freak on kind of thing. It doesnt feel like a traditional workout. You get to move your body, but you also get to shift your mind in a way thats really cathartic. She currently tunes in to livestreams about four times a week from an empty area [in the house] with a good-size mirror.

Naomi also does strength-training sessions created for her by her longtime Los Angelesbased personal trainer, Keith Anthony. Her go-to move: squats. I dont know all their names, she says, getting up out of her chair, but I just did this one the other day, where youre on one leg; can you see me? Indeed, I can: She demonstrates a pistol squat, in jeansa move that, after three sets of eight on each leg, renders her almost unable to walk up and down the stairs. Other loves: goblet squats with a 25-pound weight (three sets of 20, until I get to failure, she says) and jackknife crunches with a stability ball. Weve been told the endorphins keep you going and are great for anxiety and depression, she says. That all sounded good, but now, we really get to experience that.

She relies on other strategies for mental wellness too. Naomi has been open about seeking therapy: To prepare for the 2017 miniseries Gypsy, in which she plays a cognitive behavioral therapist who infiltrates the lives of her patients, Naomi did numerous sessions with, you guessed it, a cognitive behavioral therapist. I found the research very interesting, she says. It felt like a practical way of dealing with and managing specific issues within a certain time frame. Being able to improve or change your behavior by breaking patterns makes it tangible and beneficial. She also dug deep during the time she spent with her own therapist, whose guidance was particularly helpful during her separation from Liev Schreiber, her partner of 11 years and the father of her two children. Additionally, she uses meditation to help manage anxiety. More specifically, she practices a form of it called transcendental meditation (or TM), which involves repeating certain mantras to achieve a state of pure awarenessand shoots for 20-minute sessions every day. I try to keep it consistent. It 100 percent always makes me feel better.

Settling into the unknown (and pivoting) is becoming natural to her. The three projects she planned to shoot in 2020 remain up in the air, and shes hesitant to talk about them because she doesnt know what will be viable once its possible to gather the many necessary peoplecast, crew, hair, makeup, lightingon a set again. Two years ago, though, she branched out and invested in a business outside the entertainment industry: Naomi is a partner in Onda (wave, in Spanish), a nontoxic-skin-care store.

She first got interested in the concept when she went to visit a friend, former mag editor Larissa Thomson, and forgot to bring her toiletry bag. Thomson let Naomiwhose skin had suddenly become sensitive and prone to itchy, red, dry patchesborrow her face washes and creams, and she was blown away by the results. I think it was the combination of long workdays with lots of makeup applications, the chemicals in the products I was using at the time, and the hormonal changes I was going through, she says. Using clean products made an immediate difference.

Ideas and connections ensued, and Naomi introduced Thomson to longtime pal Sarah Bryden-Brown, thinking the two would make a good team. About a year after they launched Onda, a one-stop shop, Naomi joined the pair. I never planned to be in the day-to-day business of things, but over time, Ive gotten more involved, she says of testing new products and weighing in on how to grow the brand. Her role, however, has not come with a fussy 17-step skin-care routine. I dont cleanse in the morning, she says, though she does double-cleanse at night.

I just add moisturizer and serum, or a moisturizer with sunscreen.

And after face food, theres food food. Its three cups of coffee; an avocado toast around 11 a.m.; a big, crunchy salad for lunch (her go-to is arugula, feta, olive, tomato, cucumber, and avocado with a homemade dressing of garlic, olive oil, lemon, mustard, and vegenaise); and something hearty for dinner, like a Moroccan chickpea couscous or pasta puttanesca.

Of course, in her current world, theres also been a lot of mac and cheese and potato chips. And while shes not normally a dessert person, theres been a lot of cake too. Baking is an activity that shes found keeps her children happy even when theyre homebound. (Back to that love-hate relationship with banana bread!)

I got a few cake box mixes, she says. Normally, Ill go, Okay, now do this, dont let that go there, watch the eggs, be careful when youre separating, but now, Im like, Experiment. Do it. Make all the mess you want.

One upside of sheltering at home (besides endless cake-making) has been that the kids see more of both parents. Weve spent plenty of time together, she says, adding that she and Schreiber remain amicable by keeping the same goal in mind, which is the kids health and well-being.

Theres been a lot of family bonding, latelyNaomis brother, the photographer Ben Watts, shot her for the cover of this issue, in part because they were quarantining together. Naomi changed in the back of his truck and acted as her own glam squad. I FaceTimed with a hair and makeup person, she says, and mimes dusting her face with a brush. Im sitting there going, Okay, so where do I put this?

Ironically, in not putting too much pressure on herself right now, Naomi seems to have figured out how to be comfortable in her own skin in a very uncomfortable time. Im very impressed with these people who are saying, I cleaned out the pantry and color-coded my bookshelves and watched this documentary series and read this book, she says. Im finding that its hard to get through a lot of things. My attention span is just not as good as it could be, but I have had days where Ive had creative moments and conversations with people where weve actually come up with ideas.

There are ups and downs, she says, but the world is united for the first time in our lifetime. Thats a significant feeling. Its an optimistic sentiment that sheand the rest of uscan hold on to as we look toward the future. Leave it to Naomi to find the silver linings.

Photographed by Ben Watts Styled by Gabriela Langone Hair consultation: Ryan Trygstad using Rahua and Dyson tools. Makeup consultation: Katey Denno at The Wall Group.

You Might Also Like

Follow this link:
Naomi Watts On The Power Of Letting Go Of Perfection - Yahoo Lifestyle

So, youve hired a nanny. Unlike your 15-year-old niece who charges you $10 an hour and as much of the ice cream in the fridge as she wants to watch your kid for an evening, your nanny is a professional and should be paid as such. That means accounting for payroll items such as taxes and benefits. This provides long-term protections and bonuses for both you and the person youre employing. The nanny gains access such benefits as Medicare and Social Security, while you know that you have everything buttoned up including nanny taxes come April 15th.

So how do you pay a nanny the right way and what paperwork needs to be filled out? Heres what you need to know.

If youre planning to pay your nanny more than $2,200 year or an average of at least $183 per month you need to pay taxes. And, yes, you should pay them. In fact, both you and your nanny are in a better position when you pay and report taxes with tax breaks for you and benefits for them. Its also the law.

We do it not just to follow the law but because it is the morally right thing to do, says father and employment law expertMichael Oswalt, Associate Professor at Northern Illinois University College of Law. Nannies are employees, not independent contractors.

Because all of our employment protections hinge on employment status, Oswalt adds, misclassifying a nanny denies them the few safety net protections that exist. In-home care work is already precarious and often poorly paid, he says. Misclassification compounds the vulnerability. Why do that to anyone especially to someone caring for your child?

Paying nanny taxes qualifies your nanny for healthcare subsidies, unemployment benefits should they lose their job due to no fault of their own (i.e. a pandemic), verifiable employment history for applying for loans, and Social Security and Medicare for when they retire.

In addition to potential tax savings, paying nanny taxes lets you rest easy that the IRS wont come knocking. If you get caught for not paying like when your former nanny applies for unemployment after your kid enters school full-time and the unemployment office sees you havent paid any taxes you can expect an audit, back taxes plus penalties and interest, and potentially tax evasion charges.That doesnt end well for anyone.

Story continues

Now that youre convinced you should pay nanny taxes, theres a bit of paperwork to tackle. While it depends, the most likely scenario is that paperwork is needed for both Federal and State taxes.

Many employment laws vary by state, so the protections provided by employee status can differ, Oswalt says. For instance, in Illinois where Oswalt resides, he is required to provide their nanny with paid sick leave. Thats not true elsewhere.

A service likeCare.coms HomePaywill take care of most of the details (direct deposit, generating the W-2, apportion all the taxes, tell you if you need to buy workers comp, etc.), but if youre going the DIY route, its important to follow these steps:

1. Get an EIN and Fill Out an I-9, a W-4, and a State Withholding Form

As your nannys employer, you need a federal Employer Identification Number (EIN).Apply for one online.Your nanny should fill out anI-9, afederal W-4 form (PDF), and a state withholding form if your state collects income tax.

2. Pay Your Nannys Salary

Tally your nannys hours, multiply it by their hourly rate, and add overtime pay to get the gross (pre-tax) amount you owe. Subtract Social Security and Medicare taxes, income taxes, and any other state or local taxes that may apply generally about 10 percent of gross pay. The net is your nannys take-home pay, so cut that check.

3. Pay Nanny Taxes

What you deducted from your nannys pay is what you need to send to the IRS and your states tax agency.Pay your estimated federal taxes (1040) online or by maildo it every three months to avoid underpayment penalties and interest. Your states requirements may differ, so double check them and pay that, too, if necessary.

4. Prep for Tax Filing

Once the year ends, youll need to complete a few more forms for Aprils tax deadline. Provide your nanny aW-2 for their income tax returns andfile a W-2 Copy A and W-3 with the Social Security Administration. You may also need to fill out an Annual Reconciliation Form if your state requires it. Finally, youll need to submit aSchedule H, which allows you to report household employment taxes, with your federal income tax return.

Are you using a nanny share service to split childcare costs with another family? Youll both need to follow the steps above to establish yourselves as household employers with the IRS and your state, pay the nanny separately, and withhold and remit the appropriate taxes to the IRS and state. And make sure the combined rates youre paying add up to the minimum wage in your area.

Following the rules when it comes to paying a nanny or caretaker fairly and by the books ensures that they receive all the legal benefits of the work they do. These employees often become members of the family; its important to see that they are given the most you can give.

The post How to Pay a Nanny the Right Way appeared first on Fatherly.

Originally posted here:
How to Pay a Nanny the Right Way - Yahoo Lifestyle

Photo credit: YouTube

From Oprah Magazine

Lin-Manuel Miranda's hit musical Hamilton is available to watch on Disney+.

It depicts the animosity, rivalry, and subsequent duel between Alexander Hamilton and Aaron Burr, two instrumental figures in the founding of the United States.

In the film (and the original run of the play) Burr is played by Leslie Odom Jr., for which he won a 2016 Tony Award.

The rivalry between Alexander Hamilton and Aaron Burr is one of the animating forces of Lin-Manuel Miranda's Hamilton, now streaming on Disney+, culminating in the duel that takes Hamilton's life in Act II. But there's much more to Burr's story after those fateful shots were fired on July 11, 1804.

The two Founding Fathers had longstanding bad blood due to their political differences. Their mutual disdain affected both of their political careers and led not only to the end of Hamilton's life, but irrevocable changes to Burr's.

As Hamilton explores in detail, Burr and Hamilton's relationship was highly contentious. They were both rising political stars and Revolutionary War heroes, but saw eye-to-eye on little.

Burr, a member of the Democratic-Republican Party had more progressive polices than Hamilton, who was a Federalist. The former supported immigrant and women's rights, as well as a broader voting franchise. But Hamilton felt Burr was politically unprincipled and willing to change his beliefs based on what was most personally advantageous, according to History.com.

The two clashed in elections, as Burr beat Hamilton's father-in-law to secure a Senate seat in 1791, and Hamilton worked to undermine Burr's presidential run in 1800. With Burr and Thomas Jefferson tied at the ballot, Hamilton petitioned for Congress to go with Jefferson, which they ultimately did (though it's unclear what, if any, effect Hamilton's actions actually had).

When Burr became aware he would not be picked as Thomas Jefferson's vice president for his reelection campaign, he ran for Governor of New York, another election he lost in part due to criticism from Hamilton.

Story continues

After exchanging confrontational letters, a duel was organized between the two in Weehawken, New Jersey on July 11. Burr hoped that winning the duel would reinvigorate his stagnant political career, according to PBS, and was also incensed over a "despicable opinion" Hamilton shared about him to guests at a dinner party.

Though impossible to confirm, many believe that Hamilton missed his first shot of the duel deliberately, while Burr shot to kill from the very beginning. That helped turn the public sentiment against Burr, as historian David Hosack noted.

Per History.com, deaths in these sorts of duels were rare, and the public was upset by the passing of a figure as instrumental as Hamilton. Burr was able to serve the remainder of his term as vice president, despite being charged with two counts of murder.

When Burr left the vice presidential office in 1805, he was disgraced, and in his desperation came up with an elaborate scheme to establish a new country by taking control of the Louisiana territory, a move now known as The Burr Conspiracy. He collaborated with Army General James Wilkinson, who was also Governor of Northern Louisiana, and contacted several European countries to see if they would support his plan with money and manpower.

Burr's daughter, Theodosia, who is the subject of the Hamilton song "Dear Theodosia," and her husband Joseph Alston went to assist Burr in forming this new colony, and the plan was for Theodosia to eventually succeed her father as its leader, Atlas Obscura reports.

The plan crumbled, as Wilkinson eventually bowed out in order to preserve his career, and rumors about Burr's treasonous ways spread to the newspapers. Burr was apprehended just north of New Orleans at Bayou Pierre, and he eventually faced trial for treason in 1807.

Thomas Jefferson testified against Burr, saying his "guilt is placed beyond all measure." Still, Burr was not found guilty, despite both the Jefferson testimony and the presentation of a coded letter describing the plan that he sent to Wilkinson (known as the Cipher Letter). The acquittal was due in large part to Supreme Court Justice John Marshall's rigid definition of what counted as treason.

Fearing more legal charges in states around the country, Burr spent several years in Europe, apparently attempting to get England or France to participate in a North American invasion. Theodosia apparently was instrumental in getting him out of the country.

He returned to the States in 1812, becoming a lawyer in New York and living out his days in relative obscurity. Burr was briefly remarried to Eliza Jumel in 1833, but was divorced because he was reportedly recklessly spending her money on land speculation. The divorce was granted on the very day Burr died in 1836, and Jumel used Alexander Hamilton, Jr. as her lawyer.

When Burr died, he was partially paralyzed.

In his final years, Burr was financially dependent on his friends, and he suffered multiple strokes that ultimately left him partially paralyzed. He finally died in September 1836 at the age of 80 in the care of a cousin on Staten Island, New York.

Though some have lobbied for the public to celebrate Aaron Burr's life and accomplishments, his legacy was forever altered by the murder of Hamilton and his subsequent treasonous actions.

For more stories like this, sign up for our newsletter.

You Might Also Like

Read this article:
After Aaron Burr Killed Alexander Hamilton in That Infamous Duel, He Lived in Disgrace - Yahoo Lifestyle

Click here to read the full article.

Is it a bird? Is it a plane? No, its Codecasas new Jet 2020, which takes aviation-inspired design and applies it to a 230-foot superyacht. The latest creation from the Italian shipyard is the epitome of cross-pollination design in the 21st century.

Due to begin construction later this year, the 230-footer will become the shipyards new flagship. The project is the brainchild of Fulvio Codecasa, who has owned the Viareggio-based shipyard for the past 40 years. The Codecasa family, in fact, has been in the boat-building business since 1825.

More from Robb Report

While the shipyard is known for its custom designs, the Jet 2020 is unlike any other yacht it has ever built. By applying an aircrafts lines to a yachts hull, Codecasa said he wants to set a unique example that he hopes will ignite a trend.

Aeronautical design features include the rounded forward section of the yacht, with a helm area that resembles an airplanes cockpit. The central section of the superstructure is more akin to a fuselage with a sundeck, while the aft end ticks up to echo the tail of an aircraft. The main benefit of this aviation-inspired shape is large internal volume, says Codecasa, describing the interior as huge.

The aft beach club at sea level is possibly the most stylish section of the yacht. It has an elevator and is connected to a sky lounge. With floor-to-ceiling windows in the main salon and dining area, the views promise to be unrivaled. A helipad sits atop, so the owners can indulge in real flight, too. When heading ashore, a double tender area with the look of a jet engine is located along the side of the yacht.

The bow area on the main deck is dedicated to the owners suite. There are four guest cabins on the lower deck. For those looking to maximize outdoor time, the sundeck is a massive 66 feet by 33 feet, with a covered gym, sunbathing pads and a 20-foot recessed swimming pool.

Story continues

While the majority of the yachts technical information has yet to be revealed, Codecasa says the Jet2020 will have other aviation-inspired tech features, like radar antennas installed inside a carbon-fiber dome. He said they will be designed in the typical style of the AWACS aircraft, the Boeing E-3 Sentry.

The Jet2020 will be built to Lloyds and MCA standards, so it can be registered under the most important international certification flags.

Best of Robb Report

Sign up for Robb Report's Newsletter. For the latest news, follow us on Facebook, Twitter, and Instagram.

See the original post here:
This New 230-Foot Superyacht Looks Like a Floating Jumbo Jetand Thats the Point - Yahoo Lifestyle

NEW YORK (AP) The last few weeks I spent in New York City, the soundtrack of my days went like this: police helicopters circling, firecrackers startling, uniform chants for justice rising into the air.

The noise was constant particularly following what had been months of silence as the city that never sleeps went into a deep slumber. Since mid-March, the only sound we'd heard came from ambulances carrying the thousands of people who would become victims to a startling virus as the city became the epicenter.

I had dreamt of living in New York City since I was 13. I had come here from Southern California for the first time with my middle school choir class. We stayed in a hotel near Times Square, and I remembered the noise the constant, looping sound of a city in motion. The subway rumbled underneath our feet as New Yorkers existed outside, creating a cacophony.

It was beautiful. I remember thinking: This is what life must sound like.

Now, more than a decade later, my time with New York is limited but also, somehow infinite. The days now have no beginning or end. We are not working from home but, rather, living at work. And now I find myself with too much time to recollect about a whirlwind romance with the only place I have ever felt at home.

In a 1967 essay, Goodbye to All That, Joan Didion wrote: I am not sure that it is possible for anyone brought up in the East to appreciate entirely what New York, the idea of New York, means to those of us who came out of the West and the South.

In many ways, I am so lucky. I got to have New York City for three beautiful and challenging years. For some, that may seem short, but I came alive here. I moved into a 300-square-foot apartment in the East Village in the summer of 2017, and life as I knew it changed.

I attended my dream school in New York. I met the girl who is now my best friend at a coffee shop near Washington Square Park. I fell in love for the first time while waiting for a table on the Upper West Side. I had my first national byline on the third floor of 30 Rock. I experienced my first heartbreak in an apartment deep in Bushwick. I graduated with my masters on a blistering hot summer day at Yankee Stadium.

Story continues

I moved to four apartments in three years. I cried on every train line in the city's subway system but one. I truly lived in New York. And now, as the city is battered and broken down, as buildings remain closed and most stores are boarded up, I am leaving. Not because of the virus, but to start a new job.

Like many, I have spent these past three months mourning the life we had before this virus. The memories and lives lost. But I am also mourning the noise of a city in motion. And now, I wonder, will the sidewalks of New York ever be filled to the brim again? Will there be a day when the neighborhood barber shops, restaurants, and dive bars are busy again?

I dont know. But I know one thing. The other night, as protests erupted in each of the citys five boroughs, a beautiful sound poured into the corners and crevices of my Brooklyn neighborhood. It interrupted the chants, the helicopters and the fireworks. It was the sound of Martin Luther King Jr.s I Have A Dream speech.

It echoed off the brownstones and spilled into the bodegas. It was the new soundtrack of a city in motion.

___

Virus Diary, an occasional feature, showcases the coronavirus pandemic through the eyes of Associated Press journalists around the world. Farnoush Amiri works for the AP/Report for America Statehouse News Initiative. Report for America is a nonprofit national service program that places journalists in local newsrooms to report on undercovered issues. Follow her on Twitter at http://twitter.com/FarnoushAmiri

Continue reading here:
VIRUS DIARY: Goodbye to NYC, and to its unforgettable sounds - Yahoo Lifestyle